Navigation Links
NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
Date:10/27/2008

Data presented at annual ICAAC/IDSA meeting in Washington, D.C.

WASHINGTON, Oct. 27 /PRNewswire/ -- A novel topical therapy for nail fungus, NB-002, has demonstrated a new topical approach to healing nail fungus by penetrating skin pores and diffusing through the skin that surrounds the entire nail plate, according to a study conducted by NanoBio Corporation.

The data represent a unique approach to treating nail fungus (onychomycosis), which resists topical therapies because they cannot penetrate the nail and access the site of infection. The results were reported this morning at the 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, D.C.

"In testing NB-002 on human cadaver skin, we have demonstrated that the lotion permeates and then laterally diffuses across tissue plains in the epidermis and the dermis to more than 1 centimeter away from the site of application," said Susan Ciotti, Ph.D., director of formulations and research and development, and presenting author of the data.

"The average great toenail measures 22 millimeters across, so we are able to deliver NB-002 across the entire span of an infected human large toenail, a huge advance in the treatment of onychomycosis," Ciotti said.

Because of its novel mode of penetration and diffusion, NB-002 is able to achieve 50 times the minimum drug concentration required to kill the fungus in the very center of the nail bed. Only 4 micrograms per gram of tissue are required for NB-002 to kill fungal infections.

Newer, more effective therapies for nail fungus are important because onychomycosis remains a large unmet medical need, according to the NanoBio scientists. Oral systemic medications are plagued by serious hepatic and cardiac toxicity concerns, while current topical medications are not effective because they are unable to penetrate to the site of i
'/>"/>

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis
2. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
3. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
4. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
5. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
6. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
7. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
8. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
9. Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus
10. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
11. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...
(Date:11/25/2009)...CAGO and STAFA, Switzerland, Nov. 25 /PRNewswire/ ...acturer of innovative hearing solutions, presented... Conference, focusing on the special needs of the ...leading experts in aging and audiology from around...veryday with older people with hearing loss for an...
(Date:11/25/2009)...GEWATER, N.J., Nov. 25 The FDA gra...avirine) tablets, a non-nucleoside reverse transcr...RTI specifically indicated for use in treatment-ex...ilure with HIV-1 strains resistant to an NNRTI and...al approval is based on 48-week data from two Phas...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AcademyHealth Annual Research Meeting begins Sunday 50091 1Glucose challenge test is accurate and economical for diabetes and prediabetes screening 50089 1Glucose challenge test is accurate and economical for diabetes and prediabetes screening 50089 2Glucose challenge test is accurate and economical for diabetes and prediabetes screening 50089 3CWRU receives 245 million from Ohio Third Frontier Commission 9009 1CWRU receives 245 million from Ohio Third Frontier Commission 9009 2CWRU receives 245 million from Ohio Third Frontier Commission 9009 3
(Date:11/27/2009)...conomic burdens, study predicts , , FRID...le with diabetes in the United States is expected ...icts. , That would bring the total by 2034 to a... 23.7 million today. , , At the same time, the c...the study also warns, rising from an estimated $11...
(Date:11/27/2009)... anatomy education apps from Modality and Lippinco...earning opportunities for iPhone and iPod touch ,...er 27, 2009 -- Modality, Inc. and Lippincott Wil...luwer Health, today announced the availability of ... Clemente’s Anatomy, Rohen’s Photograp...
(Date:11/26/2009)... strains or worse , , THURSDAY, Nov. 26 ...h stuffing your turkey full to bursting, but you m...ase as you pack for holiday trips. , More than ...l emergency rooms, doctors, offices, clinics and o...es, such as muscle strains, pulls and tears, accor...
(Date:11/26/2009)... announces a highly effective and unconventional b...make an economic recovery. , ...type of challenge that could send ailing holiday s... Benton, business growth expert and author of the ... Rfactor Intensive . “Fear is one of the b...
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofMagnetic...entificInc.,aleadingproviderofsoftwareenablingtech...t4DAdvancedVisualizationsoftware. ,, Thisinnova...tbasedmedicalimagingofferinginthemarket.CalgarySci...taccess-requiringnosoftwaredownload,andrunsonanyMa...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...ernment has launched a unique healthcare scheme to...al services in the rural areas//. Additionally, do...would be provided appropriate medical facilities t... a body of the health ministry, in June. 'Ar...
... that popularize their calorie-dense, low-nutrient...hers from the Harvard School of Public Health (HSP...ct of obese kids watching television. // The study... kids tend to eat the foods that are advertised, a...
...loyees of the BEST and 300 city policemen are curr...50 and 100 HIV positive cases have been detected /...t is feared that the number of HIV/AIDS cases amon...est their HIV status. Eventually, they land up at ...
...oing training abroad are facing a sudden turn of e...hich stipulates that non-EU doctors// need to poss...will obviously leave many thousands in quandary an...of doctors exceeding the demand. UK has been ...
...esearchers in University of Florida, the reason ob...hey receive at the playground.// The study says...ations where they have been picked on before, such...d author said, "We found that as rates of peer vic...
...kidney transplant is agonizing, but taking the med...e so. But it has emerged that more than 25 out of ...ons.// Now, a nursing researcher at the Unive...n the MU Sinclair School of Nursing is using the M...
Other Medicine News:Health News:New Healthcare Scheme For Rural Areas Launched 2Health News:BEST Employees And City Policemen Seek HIV/AIDS Treatment 2Health News:NHS Medics at the Receiving End 2
DHS® Basic Implant Set
BioElectron Orthopak
...e Pulsed ElectroMagnetic Field (PEMF) bone growth ...nsurgical option for long bone and small bone nonu...edic brace, or clothing without lessening its effe...one compact, lightweight unit including success ra...
Interference Screws
Medicine Products: